Today: 10 June 2026
Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

New York, Jan 12, 2026, 15:11 EST — Regular session.

  • Shares of Texas Instruments slipped roughly 0.2% in afternoon trading.
  • Chip stocks mostly gained, but TXN trailed the pack.
  • Investors are eyeing TI’s Jan. 27 earnings for signs on industrial and auto demand.

Texas Instruments shares slipped slightly on Monday afternoon, lagging behind the steadier semiconductor sector. The stock dipped roughly 0.2% to $189.85.

The split matters since Texas Instruments serves as a bellwether for analog chips — those crucial components inside factory equipment, cars, and common electronics. With its next update looming, positioning is already shifting.

Macro noise isn’t doing any favors. A Justice Department probe touching Federal Reserve Chair Jerome Powell, plus the political fallout, has stirred up fresh doubts over Fed independence, rattling both rates and currency markets.

Markets have shifted into jittery, uneven moves instead of clear trends. “Gold has strengthened, equities have wobbled, and the yield curve has steepened a little,” noted Damien Boey, portfolio manager at Wilson Asset Management. https://www.reuters.com/business/investors…

Texas Instruments wasn’t the only one to stall, yet it stood apart from the broader trend: the iShares Semiconductor ETF gained around 0.7%, and Nvidia’s stock climbed about 1% during that period.

A few investors are mainly focused on avoiding missteps ahead of a headline-heavy week. “We need to see some type of action before the market will actually react to it in a meaningful way,” said Jordan Rizzuto, chief investment officer at GammaRoad Capital Partners. https://www.reuters.com/business/finance/g…

Texas Instruments is gearing up for its next major event: the Q4 and full-year 2025 earnings report. The company plans to webcast the conference call on Tuesday, Jan. 27, at 3:30 p.m. Central time. CEO Haviv Ilan and CFO Rafael Lizardi will be leading the discussion.

Traders are focused on any change in order patterns and inventory levels—that is, whether customers are still clearing out old chips or have returned to steady buying, especially in industrial and automotive sectors.

The sector scene is active as well. Taiwan Semiconductor is set to unveil a hefty jump in quarterly profits, fueled by sustained AI infrastructure demand. This could give chip sentiment another boost.

This week’s calendar features U.S. inflation figures alongside a busy stretch of corporate earnings. Both have the potential to shake bond yields sharply — a key factor for long-duration tech stocks, including under-the-radar players like TI.

There’s a clear risk here: should rates surge or industrial demand stay weak, TI’s cautious streak could persist. The company has flagged tariff-related uncertainty and a slower rebound in analog sales before, and investors are still jittery about hearing that again.

As the week winds down, eyes remain on TXN to see if it can hold its ground alongside the broader chip sector. Attention will then turn to Jan. 27, when management’s guidance and remarks are expected to chart the stock’s next move.

Stock Market Today

  • Citi and Google Warn Quantum Computing Poses Greater Risk to Bitcoin Than Ethereum
    June 10, 2026, 1:55 PM EDT. Citi and Google Quantum AI research reveal Bitcoin faces significantly higher risk from quantum computing attacks than Ethereum. Quantum computers could potentially derive Bitcoin private keys from public keys in minutes, threatening security earlier than expected by 2028. Bitcoin's elliptic curve cryptography is vulnerable during brief public key exposures in transactions, while Ethereum is less exposed due to different technology and governance. Despite theoretical upgrades, Bitcoin's conservative, slow governance makes timely quantum-proofing challenging. Institutional holders like Bit Digital are shifting their treasury from Bitcoin to Ethereum, citing this quantum risk as pivotal. This emerging threat signals critical urgency for Bitcoin stakeholders amid accelerating advances in quantum computing.

Latest articles

T1 Energy Stock Just Got Hit—KORE Deal Filing Puts Dilution Back in Focus

Trina Solar Faces Short-Seller Heat Over Tax Credits, T1 Energy Stock Drops

10 June 2026
T1 Energy shares plunged nearly 8% to $7.79 after Fuzzy Panda Research published whistleblower-backed invoices alleging $65 million in first-quarter solar-cell purchases from Trina Solar, challenging T1’s eligibility for key U.S. manufacturing tax credits and casting doubt on its reported $9.1 million adjusted EBITDA, just as the company pursues a major battery storage and AI infrastructure acquisition.
Constellation Energy Earnings Preview: AI Power Bet Faces a 7% Stock Test

Constellation Energy Drops; Three Mile Island Restart News Runs Into AI Power Sector Selloff

10 June 2026
Constellation Energy shares fell 3.3% to $243.32 despite regulatory progress for the Crane Clean Energy Center, as investors repriced AI-linked power stocks; the next key catalyst is the NRC’s public-comment deadline on July 8 ahead of a projected final environmental decision in September, with stock sentiment hinging on regulatory milestones and data center power demand.
Caterpillar Slips, Drags Down Dow as AI Rally Gets Tested

Caterpillar Slips, Drags Down Dow as AI Rally Gets Tested

10 June 2026
Caterpillar shares plunged 6.2% to $858, erasing recent gains and dragging the Dow lower, as investors dumped industrials on inflation, rate, and geopolitical fears; all eyes now turn to whether Caterpillar’s record $62.7 billion backlog and surging AI-linked power demand can withstand rising tariff costs ahead of August’s Q2 results.
Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows
Previous Story

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal
Next Story

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Go toTop